" class="no-js "lang="en-US"> News Archives - Page 14 of 267 - Medtech Alert
Thursday, September 18, 2025

Sort by:

Date

Top Post

Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease

An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]

Woebot Health Names Matt Borowiecki Chief Financial Officer

Woebot Health, a mental health ally for people and businesses, today announced that it has […]

ISA Pharmaceuticals to Present First Clinical Trial Data of ISA101b and Libtayo® in Head and Neck Cancer

ISA Pharmaceuticals, a clinical-stage biotechnology company developing immunotherapies to treat cancers and serious infectious diseases, […]

Transgene and BioInvent Report Positive Phase Ia Data on Oncolytic Virus BT-001 in Solid Tumors

Transgene, a biotech company that designs and develops virus-based immunotherapeutics against cancer, and BioInvent International […]

HuidaGene Therapeutics Appoints Alvin Luk as Chief Executive Officer

HuidaGene Therapeutics, a clinical-stage genome-editing company, today announced the appointment of gene therapy industry veteran, […]

Synthego Opens State-of-the-Art GMP Guide RNA Manufacturing Facility to Enable CRISPR Genomic Medicines

Synthego, a leading provider of genome engineering solutions, announced today the opening of its state-of-the-art […]

Endo Announces Agreement with MAIA Pharmaceuticals to Distribute Bivalirudin Injection in Ready-to-Use Vials

Endo International announced today that its subsidiary Endo Ventures has executed an agreement with MAIA […]

ElevateBio Announces $401 Million Series D Financing to Further Accelerate Growth

ElevateBio, a technology-driven company focused on powering the creation of life-transforming cell and gene therapies, […]

INOVIO Announces Orphan Drug Designation for INO-3107 for the Treatment of Recurrent Respiratory Papillomatosis

INOVIO, a biotechnology company focused on developing and commercializing DNA medicines to help treat and […]

WHO launching Polio Eradication Campaign in Pakistan using PharmaJet Precision Delivery System

PharmaJet®, a company engineering precision delivery systems that overcome the challenges of vaccine delivery, has […]

bit.bio Launches New Custom Disease Model Cells Offering, Advancing Disease Research and Drug Discovery

bit.bio, a cell coding company, has launched its new Custom ioDisease Model Cells offering. This […]

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more